Preoperative Sleep Quality and Postoperative Outcomes in Breast Surgery

Last updated: April 26, 2026
Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Breast Cancer

Inflammation

Acute Pain

Treatment

Preoperative Sleep Quality Assessment (PSQI)

Clinical Study ID

NCT07547774
2026-04/76
  • Ages 18-70
  • Female

Study Summary

Sleep quality is a key physiological factor influencing immune function, inflammatory response, and pain perception. This prospective observational study aims to evaluate whether preoperative sleep quality predicts postoperative inflammation, pain severity, and analgesic consumption in patients undergoing elective breast cancer surgery.

Preoperative sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI). Systemic inflammatory response will be evaluated using the Systemic Immune-Inflammation Index (SII), calculated from routine hematological parameters. Postoperative pain will be assessed using the Visual Analog Scale (VAS), and analgesic consumption will be recorded within the first 24 hours.

The study aims to determine whether poor sleep quality is associated with increased inflammatory response, higher pain scores, and greater analgesic requirement.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Female patients aged 18 to 70 years

  • Scheduled for elective breast cancer surgery

  • American Society of Anesthesiologists (ASA) physical status I to III

  • Able to understand and complete the Pittsburgh Sleep Quality Index (PSQI)

  • Willing to participate in the study

  • Provided written informed consent

Exclusion

Exclusion Criteria:

  • Active infection

  • History of chronic inflammatory disease or autoimmune disease

  • Use of steroids or immunosuppressive drugs within the past 6 months

  • Known diagnosis of obstructive sleep apnea syndrome

  • Severe cognitive impairment preventing completion of the questionnaire

  • Planned emergency surgery

  • Refusal to participate or failure to provide informed consent

Study Design

Total Participants: 150
Treatment Group(s): 1
Primary Treatment: Preoperative Sleep Quality Assessment (PSQI)
Phase:
Study Start date:
April 01, 2026
Estimated Completion Date:
July 15, 2026

Study Description

Sleep plays a crucial role in regulating immune responses, inflammatory pathways, and pain modulation. Sleep disturbances have been associated with increased pro-inflammatory cytokine activity and altered pain perception.

Surgical procedures represent a significant physiological stressor that triggers inflammatory responses and postoperative pain. Identifying modifiable preoperative factors that influence these outcomes is of clinical importance.

This prospective observational study will be conducted in patients undergoing elective breast cancer surgery. Preoperative sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI). Inflammatory response will be evaluated using the Systemic Immune-Inflammation Index (SII), calculated from neutrophil, lymphocyte, and platelet counts.

Postoperative pain intensity will be assessed using the Visual Analog Scale (VAS), and total analgesic consumption within the first 24 hours will be recorded.

The study aims to determine whether preoperative sleep quality is an independent predictor of postoperative inflammatory response, pain severity, and analgesic requirement.

Connect with a study center

  • Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital Clinic of Anesthesiology and Rea

    Ankara, Yenimahalle 06200
    Turkey (Türkiye)

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.